Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37424111)

  • 1. Isoliensinine augments the therapeutic potential of paclitaxel in multidrug-resistant colon cancer stem cells and induced mitochondria-mediated cell death.
    Manogaran P; Anandan A; Vijaya Padma V
    J Biochem Mol Toxicol; 2023 Aug; 37(8):e23395. PubMed ID: 37424111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of cisplatin resistance by neferine/isoliensinine and their combinatorial regimens with cisplatin-induced apoptosis in cisplatin-resistant colon cancer stem cells (CSCs).
    Manogaran P; Somasundaram B; Viswanadha VP
    J Biochem Mol Toxicol; 2022 Mar; 36(3):e22967. PubMed ID: 34921482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neferine and isoliensinine enhance 'intracellular uptake of cisplatin' and induce 'ROS-mediated apoptosis' in colorectal cancer cells - A comparative study.
    Manogaran P; Beeraka NM; Huang CY; Vijaya Padma V
    Food Chem Toxicol; 2019 Oct; 132():110652. PubMed ID: 31255669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-β signaling axis in paclitaxel-resistant colon cancer.
    Zhao J; Xue Y; Pan Y; Yao A; Wang G; Li D; Wang T; Zhao S; Hou Y
    J Cell Physiol; 2019 May; 234(5):7051-7061. PubMed ID: 30387134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
    Karthikeyan S; Hoti SL; Nazeer Y; Hegde HV
    Oncotarget; 2016 Jul; 7(27):42353-42373. PubMed ID: 27304668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
    Podolski-Renić A; Andelković T; Banković J; Tanić N; Ruždijić S; Pešić M
    Biomed Pharmacother; 2011 Aug; 65(5):345-53. PubMed ID: 21775090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin.
    Kobayashi Y; Seino K; Hosonuma S; Ohara T; Itamochi H; Isonishi S; Kita T; Wada H; Kojo S; Kiguchi K
    Gynecol Oncol; 2011 May; 121(2):390-4. PubMed ID: 21272926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells.
    Byun JM; Lee DS; Landen CN; Kim DH; Kim YN; Lee KB; Sung MS; Park SG; Jeong DH
    Acta Oncol; 2019 Nov; 58(11):1594-1602. PubMed ID: 31257975
    [No Abstract]   [Full Text] [Related]  

  • 9. Verteporfin can Reverse the Paclitaxel Resistance Induced by YAP Over-Expression in HCT-8/T Cells without Photoactivation through Inhibiting YAP Expression.
    Pan W; Wang Q; Zhang Y; Zhang N; Qin J; Li W; Wang J; Wu F; Cao L; Xu G
    Cell Physiol Biochem; 2016; 39(2):481-90. PubMed ID: 27383277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.
    Chen FQ; Zhang JM; Fang XF; Yu H; Liu YL; Li H; Wang YT; Chen MW
    Acta Pharmacol Sin; 2017 Jun; 38(6):859-873. PubMed ID: 28260803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis.
    Mohammad IS; He W; Yin L
    Pharm Res; 2018 Feb; 35(4):77. PubMed ID: 29488114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
    Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells.
    Pellegrini E; Multari G; Gallo FR; Vecchiotti D; Zazzeroni F; Condello M; Meschini S
    Toxicol Appl Pharmacol; 2022 Jan; 434():115816. PubMed ID: 34856211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.
    Wang Y; Yu L; Han L; Sha X; Fang X
    Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly expressed STAT1 contributes to the suppression of stemness properties in human paclitaxel-resistant ovarian cancer cells.
    Wang F; Zhang L; Liu J; Zhang J; Xu G
    Aging (Albany NY); 2020 Jun; 12(11):11042-11060. PubMed ID: 32516753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P-glycoprotein-mediated multidrug resistance.
    Anbazhagan R; Muthusamy G; Krishnamoorthi R; Kumaresan S; Rajendra Prasad N; Lai JY; Yang JM; Tsai HC
    Biotechnol Bioeng; 2021 Mar; 118(3):1213-1223. PubMed ID: 33289076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
    Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
    Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism.
    Bashmail HA; Alamoudi AA; Noorwali A; Hegazy GA; Ajabnoor GM; Al-Abd AM
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31968657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
    Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
    Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.